Evidence map›Paper›PMID 25943157›Full record

ReviewPathogens and global health2015

Advances in genetics and genomics: use and limitations in achieving malaria elimination goals.

Sharmini Gunawardena, Nadira D Karunaweera

Open access · greenAbstract readReview
In one paragraph

Review in Pathogens and global health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Infection and drug resistance · 2023
    Article
  2. Article
  3. Review
  4. Dynamics ofPathogens and global health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sharmini Gunawardena
Nadira D Karunaweera
University of Colombo · LK

Funding

Study of cutaneous leishmaniasis in Sri Lanka caused by L.donovaniR01AI099602 · NIAID · UNIVERSITY OF COLOMBO · PI KARUNAWEERA, NADIRA DHARSHANI · 2012 to 2016
$635k
NIAID NIH HHS R01AI099602
6 · The paper itself

Abstract

Success of the global research agenda towards eradication of malaria will depend on the development of new tools, including drugs, vaccines, insecticides and diagnostics. Genetic and genomic information now available for the malaria parasites, their mosquito vectors and human host, can be harnessed to both develop these tools and monitor their effectiveness. Here we review and provide specific examples of current technological advances and how these genetic and genomic tools have increased our knowledge of host, parasite and vector biology in relation to malaria elimination and in turn enhanced the potential to reach that goal. We then discuss limitations of these tools and future prospects for the successful achievement of global malaria elimination goals.

Indexed as

Drug DiscoveryGenomicsInsecticidesMalaria VaccinesAnimalsAnophelesAntimalarialsDisease EradicationGoalsHost-Parasite InteractionsHumansInsect VectorsMalariaMosquito ControlAntimalarialsInsecticidesMalaria VaccinesEradication,Genetic diversity,Infectious disease,Malaria controlParasitic disease,Plasmodium,Vaccines,

Identifiers

PMID25943157
PMCPMC4455354
OpenAlexW1480226350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.